First Tracks Biotherapeutics, Inc. (TRAX) at a glance

First Tracks Biotherapeutics, Inc. (TRAX) is a Healthcare company. It trades at $17.85. It does not pay a dividend. Vestovix scores it 48/100 overall. Its strongest dimension is Safety (60/100) and its weakest is Momentum (31/100).

Price

$17.85

Market cap

n/a

P/E ratio

n/a

Dividend yield

None

Beta

n/a

52-week range

$14.72 to $26.80